CD4 and Kaposi's sarcoma: Clinical responseof KS,Skin: tumor measurements of 5 indicator skin lesions. Assessment ofKS as per AMC RKS 02 (www.amc.uab.edu), photography of indicator lesions with metric tape in the frame,Visceral: chest radiograph and endoscopy, where necessary, bronchoscopy,Safety and toxicity by DAIDS Toxicity criteria, Immunological andvirological response to HAART as measured by CD4 and HIV-viral load,QOL by EORTC QLQ C30, Adherence